Migraine trials in Norway
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationBiological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine
- Where
- Bodø
- Age
- 18 years to 55 years
- People
- 60
- Run by
- Nordlandssykehuset HF
See details and how to joinNCT07832032 - Phase 3Taking peopleThe Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind trial (NorMig)
- Where
- Aalesund, Bergen, Brumunddal, Graalum, Kristiansand S, Namsos, Oslo, Skien, Stavanger, Tromsoe, Trondheim
- Age
- 18 years and over
- People
- 550 worldwide
- Run by
- Oslo University Hospital HF
See details and how to join2024-517981-40-00 · EU 2024-517981-40-00 - Phase 2Taking peopleProphylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
- Where
- Bergen, Lørenskog, Oslo, Tromsø, Trondheim
- Age
- 18 years to 65 years
- People
- 300
- Run by
- St. Olavs Hospital
See details and how to joinNCT06485336 - Phase 2Taking peopleProphylactic Treatment With Atorvastatin for Episodic Migraine.
- Where
- Bergen, Lørenskog, Oslo, Tromsø, Trondheim
- Age
- 18 years to 65 years
- People
- 450
- Run by
- St. Olavs Hospital
See details and how to joinNCT06248671 - Phase 2Taking peopleAtorvastatin in episodic migraine
- Where
- Bergen, Lørenskog, Oslo, Tromsø, Trondheim
- Age
- 18 years to 64 years
- People
- 450
- Run by
- St. Olavs Hospital HF
See details and how to join2022-502176-23-01 · EU 2022-502176-23-01 - Phase 2Not yet taking people in NorwayOmaMig Pilot
- Where
- Oslo
- Age
- 18 years to 64 years
- People
- 25
- Run by
- Oslo University Hospital HF
See details and how to join2025-522448-41-00 · EU 2025-522448-41-00 - No phaseTaking peopleReal-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- Where
- Lillestrøm
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07159750 - Phase 3Taking peopleThe Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy
- Where
- Grålum, Kristiansand, Lillehammer, Oslo, Skien, Trondheim
- Age
- 18 years to 70 years
- People
- 450
- Run by
- Oslo University Hospital
See details and how to joinNCT07040813 - Phase 2Taking peopleAtorvastatin in chronic migraine (StainMigChronic)
- Where
- Bergen, Lorenskog, Oslo, Tromsoe, Trondheim
- Age
- 18 years to 64 years
- People
- 300
- Run by
- St. Olavs Hospital HF
See details and how to join2022-502177-42-02 · EU 2022-502177-42-02